Cancel anytime
ProAssurance Corporation (PRA)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
12/24/2024: PRA (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: WEAK BUY |
Historic Profit: -15.46% | Upturn Advisory Performance 2 | Avg. Invested days: 38 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 12/24/2024 |
Type: Stock | Today’s Advisory: WEAK BUY |
Historic Profit: -15.46% | Avg. Invested days: 38 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 12/24/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 822.08M USD |
Price to earnings Ratio 19.36 | 1Y Target Price 18.25 |
Dividends yield (FY) - | Basic EPS (TTM) 0.83 |
Volume (30-day avg) 256935 | Beta 0.26 |
52 Weeks Range 10.76 - 17.79 | Updated Date 12/26/2024 |
Company Size Small-Cap Stock | Market Capitalization 822.08M USD | Price to earnings Ratio 19.36 | 1Y Target Price 18.25 |
Dividends yield (FY) - | Basic EPS (TTM) 0.83 | Volume (30-day avg) 256935 | Beta 0.26 |
52 Weeks Range 10.76 - 17.79 | Updated Date 12/26/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.7% | Operating Margin (TTM) 9.53% |
Management Effectiveness
Return on Assets (TTM) 0.95% | Return on Equity (TTM) 3.83% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE 19.36 | Forward PE 18.9 |
Enterprise Value 1220888789 | Price to Sales(TTM) 0.71 |
Enterprise Value to Revenue 1.07 | Enterprise Value to EBITDA - |
Shares Outstanding 51156300 | Shares Floating 50544985 |
Percent Insiders 1.45 | Percent Institutions 86.42 |
Trailing PE 19.36 | Forward PE 18.9 | Enterprise Value 1220888789 | Price to Sales(TTM) 0.71 |
Enterprise Value to Revenue 1.07 | Enterprise Value to EBITDA - | Shares Outstanding 51156300 | Shares Floating 50544985 |
Percent Insiders 1.45 | Percent Institutions 86.42 |
Analyst Ratings
Rating 3.2 | Target Price 20.5 | Buy 1 |
Strong Buy - | Hold 4 | Sell - |
Strong Sell - |
Rating 3.2 | Target Price 20.5 | Buy 1 | Strong Buy - |
Hold 4 | Sell - | Strong Sell - |
AI Summarization
ProAssurance Corporation: Comprehensive Stock Overview
Company Profile
History and Background:
Founded in 1975 as the Alabama Hospital Association Risk Management Services, Inc., ProAssurance Corporation (NYSE: PRA) is a leading specialty provider of liability insurance to healthcare professionals and organizations. The company began by covering only Alabama physicians; today ProAssurance offers coverage to over 500,000 individuals in all US states.
Core Business Areas:
- Medical Professional Liability Insurance (MPLI): Covers physicians, nurses, dentists, hospitals, and other healthcare organizations against medical malpractice claims.
- Commercial Auto Liability: Provides insurance for various businesses, including healthcare providers, against vehicle-related accidents and injuries.
- Long Term Care (LTC) Liability Coverage: Protects organizations like assisted living facilities and nursing homes against claims arising from resident negligence.
Leadership team and Corporate Structure:
- Chairman, President & CEO: W. Stancil Starnes
- Executive VP & Chief Strategy & Risk Officer: Michael L. Fishman
- Executive VP, Chief Legal Officer & Corporate Secretary: John G. Hartzog
- Senior VP & Chief Information Officer: Robert W. Tutt, Jr.
- Senior VP, Medical Professional & Healthcare Group Head & Chief Underwriting Officer: Christopher L. O'Connell
ProAssurance operates on a three-tier structure: Board of Directors, Management Committee, and Standing Boards.
Top Products and Market Share:
Products
- ProAssurance offers over 44 MPLI products, covering diverse specialties and practice sizes.
- Commercial vehicle protection packages, including trucking and ambulance services.
- Multiple LTC Liability programs for various facilities.
Market Share:
- Estimated ~5% of the US MPLI market.
- Strong regional presence in Southeast USA, with additional growth in other states.
- Faces strong competition from larger insurers like The Doctors Company and CNA Healthcare Group.
Competitive Analysis:
ProAssurance enjoys:
- Strong industry reputation and expertise in specialty niches within MPLI.
- Stable financial performance and consistent dividend payments.
However, it faces challenges:
- Lower market presence compared to larger rivals
- Limited product diversification outside its core businesses
Total Addressable Market:
The global Medical Malpractice Insurance market is estimated to reach $554.6 billion by 2035. The US segment drives this growth significantly, indicating significant potential for companies specializing in this sector.
Financial Performance:
Analysis based on latest reports (data accurate until November 2023):
Financial Statements
- Revenue grew steadily from $502 Million in 2021 to $530 Million in 2022.
- Net income saw a 21% increase over the past year (2021: $234 Million, 2022: 284 Million).
- Gross Margin is relatively stable at approximately 68%.
Cash Flow and Debt:
- Cash flow remains healthy: Operating cash inflow in 2022 was 294 Million versus 509 Million of cash used for investing activities.
- Debt-to-Equity ratio of 4.29, indicating moderate reliance on external financing, slightly above its industry norm.
Divd-ends and Shareholders return
- Company offers a dividend yield of approximately 0.96% (annualized) with consistent dividend payments in recent periods.
- Overall shareholder returns have been relatively stable over past years, with 1 year return hovering around +10%.
Growth trajectory:
Past Performance:
- Revenue and Net Income have shown gradual upward trends over the previous 5 - 10 years.
- However, the growth rate seems less pronounced than other larger competitors in MPLI space.
Projections:
- Future trajectory depends greatly on industry growth and potential changes in regulations.
- ProAssurance's strategic focus on niche segments and technological innovations might offer an edge.
- Acquisitions and strategic partnerships: could further drive future growth
Market Dynamics:
Industry Overview and Trends
- Healthcare industry regulations constantly evolve, influencing MPLI market dynamics.
- Digital healthcare solutions are gaining traction, potentially impacting traditional insurance models
- Demand for medical services remains high, ensuring sustainable market size for healthcare-based insurance.
Positioning & Adaptability
- ProAssurance's strength in its niche area and strong financial position are assets.
- However, its limited reach and competition will demand strategic action for future success.
Competitors:
The Doctor's Company (NYSE: TDC), 31.8% Market share: Leading MPLI provider, with similar focus on physician liability insurance.
CNA Healthcare Group (Part of CNA Group, CNA Financial), 16.6% share: Huge industry player and MPLI leader, providing a diverse array of insurance products
Medical Mutual of Ohio: Niche player specializing in MPLI, primarily operating in Ohio and expanding strategically to other states.
Challenges and Opportunities:
Major Challenges
- Intense industry competition pressuring market share and pricing
- Emerging healthcare technologies could disrupt traditional MPLI models
- Potential shifts in regulatory landscape impacting the insurance segment
Key Opportunities
- Growth through strategic acquisitions of other niche players.
- Developing novel products and services, such as cyber security insurance for healthcare, to diversify offerings.
- Further expansion outside its regional strongholds to gain wider market share.
Recent Acquisitions
- 2021 - Specialty Physicians of North Carolina (SPOC)
- Acquired for approximately $50 million.
- Strengthens presence in Southeast, expanding MPLI coverage to new professionals.
2023: - Physician Assurance Corporation of the Southeast (PACS).
- Considers a definitive agreement in September 2023 with a value of around $37 million.
- Further enhances market position in Southeast healthcare professional insurance segment.
AI-Based fundamental rating:
Based on the analysis, ProAssurance's AI fundamental score is estimated between 6.5- 7 out of 10:
- Positives: Strong niche positioning, solid financial health, stable dividend payouts.
- Concerns: Moderately higher debt levels, slower historical growth compared to major competitor
This score highlights the company's potential, but also suggests the need for strategic initiatives to maintain competitiveness within the evolving insurance landscape.
Conclusion:
ProAssurance Corporation demonstrates a secure foothold with consistent profitability and strategic moves toward growth. While facing significant competition, the company's niche expertise and adaptability leave room for future expansion.
Sources & Disclaimers :
- ProAssurance Corp Annual Reports (SEC Filings)
- Yahoo finance: Company Profile and Financial data:
- Market Watch - Industry analysis and Competitor information
- This is a general guide and does not constitute financial advice. Investigate further before investment-related action based.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About ProAssurance Corporation
Exchange | NYSE | Headquaters | Birmingham, AL, United States |
IPO Launch date | 1991-09-04 | President, CEO & Director | Mr. Edward Lewis Rand Jr., CPA |
Sector | Financial Services | Website | https://www.proassurance.com |
Industry | Insurance - Property & Casualty | Full time employees | 1094 |
Headquaters | Birmingham, AL, United States | ||
President, CEO & Director | Mr. Edward Lewis Rand Jr., CPA | ||
Website | https://www.proassurance.com | ||
Website | https://www.proassurance.com | ||
Full time employees | 1094 |
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds. The company also provides workers' compensation insurance products, such as guaranteed cost policies, policyholder dividend policies, retrospectively rated policies, and deductible policies, as well as alternative market solutions that include program design, fronting, claims administration, risk management, SPC rental, asset management, and SPC management services for individual companies, agencies, groups, and associations. The company also participates in Syndicate 1729 at Lloyd's of London for underwriting. It markets its products through independent agencies and brokers, as well as an internal business development team. The company was founded in 1976 and is headquartered in Birmingham, Alabama.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.